Furthermore, our results imply that peri- and postoperative inhibition of SDF-1α/CXCR4 signaling may reduce the risk of increased tumor growth in patients that have increased SDF-1α levels after wounding and have incompletely resected CXCR4 positive tumors. Here, CXCL12 is linked to neoplasm.